Leishmaniasis: A new method for confirming cure and detecting asymptomatic infection in patients receiving immunosuppressive treatment for autoimmune disease

Visceral leishmaniasis (VL) in patients receiving immunosuppressant drugs for autoimmune disease has been on the rise. It is important—but difficult—to know when cure has been achieved in these patients since the withdrawal of immunosuppressants during antileishmania treatment is commonly required,...

Descripción completa

Detalles Bibliográficos
Autores principales: Botana, Laura, Ibarra-Meneses, Ana Victoria, Sanchez, Carmen, Matia, Belen, San Martin, Juan Victor, Moreno, Javier, Carrillo, Eugenia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8360552/
https://www.ncbi.nlm.nih.gov/pubmed/34339445
http://dx.doi.org/10.1371/journal.pntd.0009662

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8360552/
https://www.ncbi.nlm.nih.gov/pubmed/34339445
http://dx.doi.org/10.1371/journal.pntd.0009662

Ejemplares similares